Catalyst Pharmaceuticals (NASDAQ:CPRX) is expecting the FDA to rule on its marketing application for Firdapse, a form of 3,4-diaminopyridine used for the treatment of Lambert …
Piper Jaffray analyst Charles Duncan is out with a research note on ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), previewing the drug maker’s upcoming earnings announcement, as well as …
Analyst Charles Duncan of Piper Jaffray came away with an increased confidence in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) after attending an investor meeting with management.
Analysts weighed in on ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) with bullish sentiments following the company’s investor meeting this week.
In a research report released today, Piper Jaffray analyst Charles Duncan reiterated a Overweight rating on Inovio Pharmaceuticals (NASDAQ:INO) with a $29 price target, as the company recently …
